Stay updated on Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    A new revision entry v3.4.2 was added to the history and the previous revision v3.4.1 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T16:49:26.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision: v3.4.1 was added to the page footer and Revision: v3.4.0 was removed.
    Difference
    0.0%
    Check dated 2026-02-06T11:36:35.000Z thumbnail image
  4. Check
    19 days ago
    Change Detected
    Summary
    Revision: v3.4.1 was added to the history and Revision: v3.4.0 was removed. This update affects only the site's release notes on the history page.
    Difference
    0.0%
    Check dated 2026-02-05T14:18:05.000Z thumbnail image
  5. Check
    27 days ago
    Change Detected
    Summary
    UI enhancements were introduced: a glossary display and color-coded change highlights (green for additions, red for deletions) with a revision note updated to v3.4.0. Additionally, capitalization of 'No FEAR Act Data' was corrected and the older 'No FEAR Act data' phrasing removed.
    Difference
    0.1%
    Check dated 2026-01-29T06:22:33.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added, replacing the previous Revision: v3.3.3. This appears to be an informational site revision tag rather than a change to study content or user actions.
    Difference
    0.0%
    Check dated 2026-01-15T02:54:33.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision: v3.3.3 is added to the page, and HHS Vulnerability Disclosure and Revision: v3.3.2 are removed.
    Difference
    0.0%
    Check dated 2025-12-24T14:29:06.000Z thumbnail image

Stay in the know with updates to Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial page.